Margriet J. Collée

Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

Richard M. Brohet, Maria E. Velthuizen, Frans B.L. Hogervorst et al. · Journal of Medical Genetics · 2013 · 88 citations · Full text

Life Sciences, Genetics, Oncology +17

The <i>BRCA1</i> c. 5096G&gt;A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

Setareh Moghadasi, Huong Meeks, Maaike P.G. Vreeswijk et al. · Journal of Medical Genetics · 2017 · 85 citations · Full text

Medicine, Genetics, Oncology +17

Rare variants in XRCC2 as breast cancer susceptibility alleles: Table 1

Florentine Hilbers, Juul Wijnen, Jan C. Oosterwijk et al. · Journal of Medical Genetics · 2012 · 44 citations · Full text

Life Sciences, Genetics, Oncology +17

The counselees' self‐reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters

Joël Vos, Christi J. van Asperen, Jan C. Oosterwijk et al. · Psycho-Oncology · 2012 · 43 citations · Full text

Social Sciences, Genetics, Psychology +15

Exploring the short-term impact of DNA-testing in breast cancer patients: The counselees’ perception matters, but the actual BRCA1/2 result does not

Joël Vos, Jan C. Oosterwijk, E. Gómez et al. · Patient Education and Counseling · 2011 · 36 citations

Medicine, Counseling, Genetics +11